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Table 1. Intermolecular interactions in structures [Cu(ampf)Cl2], 1, [Cu(ampf)MeOH(NO3)2]MeOH, 2 
and [Ni(ampf)(MeOH)2NO3]NO3, 3. 
D–H...A Type D–H H...A  D...A D–H...A Symmetry operation 
   [Å] [Å] [Å] [°] 
1 N6–H6...O42 intra 0.88 2.20 2.828(5) 127  
 C7–H7...N10 intra 0.95 2.23 2.637(6) 105  
 N2–H2...Cl1 intra 0.88 2.55 3.036(4) 115  
 N11–H11...Cl2 dimer 0.88 2.26 3.131(4) 171 –x,–y,–z 
 C121–H12A...Cl2 dimer 0.98 2.68 3.654(4) 173 x, –1/2–y, 1/2+z 
 N2–H2…O42 chain b 0.88 2.45 2.973(4) 119 x, –1+y,z 
 N6–H6…Cl2 chain b 0.88 2.57 3.218(4) 131 x,1+y, z 
 C7–H7…Cl2 chain b 0.95 2.67 3.284(4) 123 x, 1+y, z 
 C43–H43C...Cl1 intercolumn 0.98 2.71 3.505(5) 138 1–x,-y,–z 
2 N6–H6...O42 intra 0.86 2.13 2.759(3) 129  
 C7–H7...N10 intra 0.93 2.27 2.667(4) 105  
 N6–H6...O501 dimer 0.86 2.22 2.900(3) 136 1–x, –y, 2–z 
 N11–H11...O401 chain b 0.86 2.06 2.900(4) 164 1–x, 1–y, 2–z 
 N11–H11...O403 chain b 0.86 2.51 3.225(4) 141 1–x, 1–y, 2–z 
 O301–H301...O503 chain c 0.82 2.50 3.159(4) 138  
 O301–H301...O504 chain c 0.82 2.00 2.794(4) 164  
 N2–H2...O301 chain c 0.86 1.96 2.769(3) 156 1–x, –y,1–z 
 C121–H12C...O403 intersheet 0.96 2.41 3.339(5) 163 1+x, y, z 
3 N6–H6...O42 intra 0.88 2.11 2.755(2) 130  
 C7–H7...N10 intra 0.95 2.27 2.665(3) 104  
 N2–H2...O501 in asym unit 0.88 1.98 2.845(4) 167  
 O201–H201...O503 in asym unit 0.84 1.86 2.692(3) 168  
 O301–H301...O404 chain a 0.84 1.99 2.784(2) 157 –1+x, y, z 
 N6–H6...O504 chain b 0.88 2.21 2.896(3) 135 x, 1+y, z 
 C7–H7...O504 chain b 0.95 2.55 3.082(3) 115 x, 1+y, z 
 N11–H11...O401 dimer 0.88 2.30 3.093(3) 151 2–x, 1–y, 1–z 
 N11–H11...O403 dimer 0.88 2.30 3.074(3) 148 2–x, 1–y, 1–z 
 
 
 
 
Fig. 1a. Packing arrangement in crystal 1 [1]. 
 
 
 
Fig. 1b. Packing arrangement in crystal 2 [1]. 
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Fig. 1c. Packing arrangement in crystal 3 [1]. 
 
Computed geometry and vibrational frequencies 
The computed metal-ligand distances are compiled in Table 2. The data reflect the main geometrical differences 
between the crystal structure obtained from the X-ray study and the isolated complex from the calculations. The 
agreement is farily good for the ligand bond lenghts.  This implies the reliability of the computed IR data of 
ampf, corresponding to most of the bands in the IR spectrum. The agreement is worse for the metal-ligand 
distances. The M–N1 and M–O15 distances are still in fair agreement, but the M–N8 bonds and the bonds with 
the NO3– and MeOH ligands deviate up to 0.3 Å. The main reason of the deviations is that the computed 
geometrical data refer to the isolated complexes, therefore cannot take into account the crystal packing effects 
and hydrogen bonding interactions between neighboring complexes. The anions are involved in strong hydrogen 
bonding interactions with the neighboring complex molecules in the crystal. Therefore they occupy an 
intermediate position between two complexes. In the isolated molecule model of the computations, there is only 
one complex these ligands can coordinate to, so they can bind more strongly to the metal (by donor-acceptor 
interactions) and to the other ligands (by hydrogen bonding interactions) resulting in smaller distances.  
 
Table 2. Comparison of selected experimental and computed bond distances (Å). 
 
                       1                      2                      3 
  Calculated X-ray Calculated X-ray Calculated X-ray 
N1=C5 1.318 1.322(5) 1.328 1.332(4) 1.325 1.317(3) 
C5–N6 1.372 1.367(5) 1.383 1.372(4) 1.387 1.382(3) 
N6–C7 1.345 1.341(5) 1.354 1.340(4) 1.346 1.338(3) 
C7=N8 1.302 1.301(5) 1.295 1.302(4) 1.303 1.289(3) 
N8–C9 1.413 1.414(4) 1.384 1.412(4) 1.398 1.411(3) 
C14=O15 1.254 1.252(4) 1.250 1.247(4) 1.240 1.240(3) 
M–N1 2.015 1.962(3) 2.000 1.962(3) 2.074 2.016(2) 
M–N8 2.312 2.008(3) 2.252 1.978(3) 2.131 2.050(2) 
M–O15 1.983 1.973(2) 1.972 1.955(2) 2.090 2.020(1) 
Cu–Cleq 2.381 2.288(1)     
Cu–Clax 2.354 2.543(1)     
M–O401    2.092 2.381(3) 2.011 2.111(8) 
M–O301complex3     2.233 2.089(2) 
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M–O501 complex2   2.058 2.539(3)    
M–O201    2.439 1.974(3) 2.084 2.065(2) 
The full list of the IR absorption bands and their assignment are given in Table 3 while the spectra are shown in 
Figure 2. The assignment of the absorption bands was aided by the computed vibrational frequencies and IR 
intensities, while the computed normal modes were visualized by the GaussView 4.1 program [2].     
The most notable feature is the high frequency of the stretchings of the formally CN and NN single bonds which 
can be attributed to the partial double-bond character of these bonds due to conjugation of the neighboring π 
bonds and the lone pairs of nitrogens. These bands appear at very close wavenumber values in the spectra of the 
three complexes, in agreement with the identical donor-acceptor interaction of the ampf ligand with the metals. 
The most important information gained from the far-IR range are the metal-ligand vibrations, which correlate 
well with values published for related complexes in Ref. [8].  
Table 3. Characteristic bandsA of the FT-IR spectra of 1, 2 and 3 and their assignments on the basis of the 
DFT calculations 
 
Experimental Calculated Intensity AssignmentB 
 
[Cu(ampf)Cl2] (1) 
 
3241s  3657  112  νNH 
3151m  3477  383  νNH 
3126m  3411  366  νNH 
3074m  3171  7  νasCH3 
3040m  3152  8  νCH 
3020m  3145  7  νasCH3 
3000m  3132  12  νasCH3 
2967m  3118  5  νasCH3 
2919m  3061  21  νsCH3 
2860m  3058  2  νsCH3 
1641s  1700  753  νC=O 
1605s  1681  184  νC=N 
1578s  1633  362  νring, βN6H, νC=O 
1548s  1606  483  νC7−N6 
1529m  1587  45  νring 
1504s  1571  119  νring, βNHring 
1466s  1496  464  νring, δasCH3 
1440m  1497  30  δasCH3 
1412s  1468  149  δasCH3, 
1355s  1397  18  δasCH3, βCH, βNH 
1312m  1339  88  νring 
1212m  1260  50  νN−N 
1159m  1218  41  νN−N, νC7−N6 
1096s  1118  58  νring, νC−CH3 
1036w  1061  5  δrCH3 
1005w  1044  2  δrCH3 
973m  981  46  νC−CH3 
964m  969  48  νC−CH3 
913m  924  16  δring, βN−CH−NH 
799s  786  26  γN6H 
773m  770  32  τring, γN6H 
743m  768  26  γN6H, τring 
732m  748  40  γNHring 
712s  727  32  γNHring 
666m  668  35  γNHring 
587w  583  15  δring 
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575w  562  40  γNHring, τring 
449w  452  5  τring, γCring−N 
343w  368  13  νCu−N8, νCu−O15, βC−C−CH3 
302sh  314  13  γC−N8 
273m  283  51  νCu−Cl 
233w  222  15  νCu−Cl 
172m  178  2  βN8−Cu−O15 
140m  146  9  βN1−Cu−N8 
106w  121  17  γCuCl2 
95sh  100  9  τCH3 
70sh  62  11  βCl−Cu−Cl 
 
[Cu(ampf)(MeOH)(NO3)2]MeOH (2) 
 
3485s  3582  714  νNH, νOH 
3229s  3417  542  νNH, νOH 
3089sh  3107  56  νasCH3 
3042sh  3152  8  νCH 
2973sh  2995  107  νsCH3 
1643s  1721  200  νC=O42 
1610s  1688  902  νC=N8 
1601s  1663  296  νC=O15 
1580sh  1636  445  νring, βN6H, νC=O 
1552s  1598  428  νC7−N6 
1529w  1584  124  νring 
1504s  1576  352  νasNO3, βOH 
1467s  1543  75  νring 
1453m  1506  212  νC5−N6, δasCH3 
1413m  1492  238  νC4−C41, δasCH3 
1384vs  1339  541  νasNO3 
1354sh  1406  17  νring 
1330sh  1388  22  βC7H 
1207m  1255  48  νN−N, νC9−N8 
1159w  1220  16  νN−N, νC9−N8 
1100m  1124  47  νring, νC−CH3 
1063w  1076  99  νsNO3, δrCH3 
1042w  1065  91  νC−O, νsNO3, δrCH3 
1007w  1054  59  νC−O, νsNO3, δrCH3 
975m  989  57  νC−CH3 
914m  926  15  βNH−CH−N, δring, νC−CH3 
850-650vbr 949  207  τOH 
839w  821  71  δNO3, γNH 
794m  792  18  γNHring, δring, νC9−N8 
773w  778  17  βC5−N6−C7 
703w  746  17  τOH, δNO3, δring 
671m  676  31  βC−C=O 
589m  597  26  δring 
581m  572  28  γNHring 
451m  455  5  τring, γC5−N6  
340w  374  16  νCu−O, νCu−N8 
303w  328  11  νCu−N8, γC7H 
279w  308  42  νCu−ONO3 
253  258  10  νCu−ONO3 
202m  224  15  βΟ−Cu−O, twNO3  
188  188  9  βN8−Cu−O, τCH3 
128m  131  6  γCuO−CH3 
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97w  98  12  βΟ−Cu−O, τCH3 
56w  52  3  twNO3 
 
[Ni(ampf)(MeOH)2(NO3)]NO3   (3) 
 
3355s,br  3385  509  νNH 
3254s,br  3010  1901  νNH, νOH 
3086sh  3172  3  νCH 
3043sh  3122  29  νasCH3 
3007sh  3057  186  νsCH3 
1650sh  1714  285  νC=O42 
1637sh  1707  496  νC=O15 
1617s  1677  639  νC=N8 
1594sh  1645  127  νring, βN6H, νC=O 
1553s  1616  509  νC7−N6 
1502m  1556  81  βOH, νN−O 
1461s  1497  489  νC4−C41, δasCH3 
1416m  1469  81  δasCH3 
1384s  1365  474  νasNO3 
1359sh  1398  51  βC7H, δsCH3 
1280w  1311  72  νC5−N6, νring, βN6H 
1204m  1254  65  νC9−N8, νN−N 
1164w  1214  55  νN−N, νC9−N8 
1098m  1119  62  νring, νC−CH3 
1045w  1074  69  νsNO3 
1031w  1061  86  νC−OMeOH 
1023w  1055  63  νsNO3, νC−OMeOH 
1010w  1036  113  νC−OMeOH 
973w  982  121  νC−CH3, δCH3, γNHring, βNH−CH−N 
962w  976  127  γNHring 
913w  924  45  βN−C−N, δring 
870-550vbr 1021  20  τOH 
839w  843  66  γN6H 
825w  824  33  γNO3 
795w  794  21  γN6H, δring, νC5−N6 
768w  777  15  βN−C−N 
663m  663  36  βC−C=O 
582sh  611  217  τOHaxMeOH 
574w  590  17  δring 
529w  567  36  γNHring, γC−C=O 
444w  455  11  τring, γC5−N6 
381w  399  24  νNi−OeqMeOH 
333m  327  19  νNi−OaxMeOH, νNi−ONO3, νNi−N8 
286w  309  27  νNi−OaxMeOH, νNi−ONO3 
274w  287  37  νNi−OaxMeOH, νNi−ONO3  
244w  255  27  νNi−N8 
210m  218  18  νNi−N8 
184w  189  11  βN8−Ni−OeqMeOH, τCH3 
129m  129  2  τCH3, γNiO−CH3(axMeOH) 
97m  93  4  γCring−CH3, βN−Ni−OeqMeOH 
70m  64  2  twNO3 
 
A In cm–1. The abbreviations vs, s, sh, m, w, br mean very strong, strong, shoulder, medium, weak and broad, 
respectively. 
B Major contributions deduced from visual observation of the computed vibrations. The abbreviations M, as, ν, 
δ, β, tw, γ, τ mean metal (Cu or Ni), asymmetric, stretch, deformation, bend, twist, wag and torsion, 
respectively.  
 
 
 
Fig. 2. FT-IR spectra of 1, 2 and 3.  
 
The mid-IR range consists of the ligand vibrations, from which the asymmetric stretching of the NO3– group (in 
2 and 3) gives rise to the highest-intense band at around 1380 cm–1. The ampf ligand provides several strong 
bands in this region due to CO, CN, NN, NO stretching, and OH and NH bending vibrations, in agreement with 
the identical donor-acceptor interaction of the ampf ligand with the metals.  
Table 4. Additional natural atomic chargesA and second-order perturbation energiesB 
Atomic charges 
Fragment Atom 1 2 3 
Cl–  Cleq –0.588   
  Clax –0.573   
NO3– O501  –0.517 
  O401  –0.544 –0.573 
MeOH O201  –0.810 –0.806 
  O301   –0.749 
Charge transfers to the metals 
Cl− → M    
E(2) LP(Cleq) → M 302.3   
E(2) LP(Clax) → M 360.4   
Σ E(2) LP(Cl) → M 662.7   
NO3− → M    
E(2) LP(O401) → M  210.7 222.4 
E(2) LP(O501) → M  214.2  
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Σ E(2) LP(O) → M  424.8 222.4 
MeOH → M    
E(2) LP(O201) → M  70.1 153.4 
E(2) LP(O301)  → M   107.1 
Σ E(2) LP(O) → M  70.1 260.5 
A The atomic charges are given in electrons. 
B M means the metal (Cu or Ni) in the complexes. Second-order perturbation energies (E(2) donor → acceptor, 
kJ/mol). The abbreviation LP means the lone pairs of the atoms. Items starting with Σ represent the summarized 
quantities for the species. For the numbering of atoms see Figures 1a – c in the main part of the paper. 
Electronic spectra 
Spectra of the complexes were recorded in MeOH in the spectral range 220 – 1400 nm. The complexes 2 and 3 
are readily soluble at 1 mmol/dm3 concentration level, but not 1. In order to improve that, the complex 1 was 
mildly heated (to about 40 oC) for app. 15 minutes. The color of solutions of Cu(II) complexes was green and 
that of the Ni(II) compound was very light blue. 
 The spectra of Cu(II) complexes are, generally, similar. In the λ range of 220-400 nm three well resolved 
absorption bands appear. The bands at ~233 nm and ~266 nm, which are present also in the spectrum of the 
starting ligand  aamp,  belong to π→π* transitions (pyrazolyl-based). A slight blue shift of the bands in the 
spectra of 1 and 2 was observed. This was not the case with [Co(ampf)(MeOH)2NO3]NO3 complex [3] where 
the bands in the ligand absorption range are considerably red-shifted and molar absorptivities several times less 
intense than those of aamp. These facts reflect a greater influence of the Co(II) on the coordinated ligand in the 
complex.  
 The third band, appearing at about 320 nm for both Cu(II) complexes, can be ascribed to LMCT. Since this 
band is rather broad and intense, it seems reasonable to assume that it is composed of two close absorptions, 
probably of π1, π2 → Cu(II). Such close transitions are not rare at pyrazole-type Cu(II) complexes [4]. 
Furthermore, for the complex 1 in this spectral range (λ~330 nm) also Cl → Cu(II) band can be expected [5]. 
Finally, the low-energy bands (λ >600 nm) in the spectra of both complexes can be attributed to d-d transitions. 
Having in mind the observed similarities in the colour and spectral characteristics of the complexes 1 and 2, and 
also of conductivity data for 2 which point to a partial dissociation of the NO3 ligands, it can be supposed that 
both complexes have a rather distorted, probably square-pyramidal Cu(II) environment. 
 The spectrum of Ni complex (3) in its high energy region is quite similar to that of the  Cu(II) complexes 
and so are the corresponding assignments of the bands. Three other, rather weak absorptions in the range λ>590 
nm (d-d transitions) and a very light blue colour of their solution may be an evidence of a preserved distorted 
octahedral Ni(II) environment in methanolic solution.  
 
Thermal analysis 
There are few data connecting the structure of the compounds with their thermal behavior in spite of the strong 
relationship between the decomposition pattern and the structure of the compounds. This is not surprising, 
because beside the structure of the compound, its macroscopic properties as well as the experimental conditions 
affect the thermal decomposition. 
 The thermal stability of the complexes is found to be the same in both gas carriers. The decomposition 
mechanism in air and nitrogen above 400 oC for 1 and for the nitrate complexes 2 and 3 above 200 oC, takes a 
different course, being more intensive in air.  
 Compound 1 is thermally stable up to 255 oC. Its endothermic decomposition begins with a DTG maximum 
at 266 oC and a DTA minimum at 270 oC and proceeds further by exothermic processes in nitrogen, too. The 
decomposition of 1 is continuous in the whole temperature range. Even with the SWI technique no intermediates 
could be isolated. The mass loss up to the first minimum of the DTG curve could fit the loss of HCl or it would 
correspond to the fragmentation of the side chains of the organic ligand. To decide which process is more likely 
we performed a qualitative reaction, the gases evolved during the decomposition bubbling through an acidic 
AgNO3 solution. As no precipitation was observed, the HCl evolution could be excluded. Hence the 
decomposition begins with the departing of organic fragments. 
 In the lack of coupled measurements, only the mechanism of solvent evaporation can be discussed. Usually 
the decomposition of isostructural compounds is very similar [6,7]. On the other hand, similar decomposition 
curves do not necessarily belong to isostructural compounds. Sometimes even very small structural differences 
may be detected by means of TA. The thermal curves of the MeOH evaporation of 2 and 3 are presented in Fig. 
3. As is evident, the mechanism of the solvent loss is almost identical, in spite of the fact that in 3 both methanol 
molecules belong to the inner coordination sphere while in 2 only one MeOH is coordinated to the metal centre. 
The evaporation of MeOH begins at 65 oC (2) and at 67 oC (3) despite of their different crystallographic 
position. The solvent evaporation is a complex process and takes place in two well separated steps. It is 
completed at 112 and 128 oC for 2 and 3, respectively. The mass loss of solvent evaporation to the 
corresponding DTG minimum, within experimental errors, agrees with the theoretical one (calcd.): 2, 13.0% 
(11.24%); 3, 11.0% (11.97%). The complexes without solvent are not stable and the decomposition proceeds 
exothermically at a slow, steady rate in both atmospheres. In spite of the similarities in MeOH evaporation, the 
rate of the process is significantly higher and begins at somewhat lower temperature in 2. This complex contains 
MeOH as crystal solvent referring probably to its lower bonding energy, including its stabilization by H-bonds 
and/or an easier diffusion through the lattice.  
 
 
Fig. 3. TG-DTG curves of 2, 3 and [Co(ampf)(MeOH)2NO3]NO3 [3]. 
 
 Supporting the complexity of the task to correlate the structural data with the thermal decomposition 
mechanism, a good example is the unexpected similarity between the mechanisms of the solvent evaporation of 
2 and 3, compounds with similar composition, but different crystal structure. It cannot be explained on the basis 
of the structural data only. In addition, they do not explain the significant differences in thermal decomposition 
of isostructural [Co(ampf)(MeOH)2NO3]NO3 [3] and 3 complexes. TA data for the cobalt(II) complex were 
repeated using the equipment and experimental conditions described in this paper. Its decomposition pattern did 
not change. The slight differences in are due to the better resolution of the instrument and to lower sample mass. 
The lower solvent content is the consequence of the storage conditions. As the interactions in Co(II) and Ni(II) 
crystals are similar, the different thermal behavior may be also a consequence of the different redox properties 
of Co(II) and Ni(II). 
 
In vitro biological activity  
The synthesized compounds and the ligand precursor (aamp) were tested for their biological activity against 
human myelogenous leukaemia K562, colon adenocarcinoma HT29, cervix carcinoma HeLa and normal foetal 
lung fibroblasts, MRC-5. In vitro cytotoxicity was evaluated by sulforhodamine B (SRB) assay after 48h-
treatment of cells. Table 3 shows the cytotoxicity of aamp and the complexes against four cell lines for the 
target compounds including Doxorubicin (Dox) as a reference drug. 
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Table 3. In vitro cytotoxycity of aamp, 1, 2 and 3 
Compounds              IC50, μMA 
    K562  HeLa  HT29  MRC-5 
 aamp   47.3  >100  0.6  >100 
 1   >100  20.2  89.0  >100 
 2   50.7  88.3  14.3  >100 
 3   >100  >100  10.13  >100 
 Dox   0.4  1.2  0.5  0.3 
A IC50 is the concentration of compound required to inhibit the cell growth by 50% compared to an untreated 
control 
The cytotoxic activity of the aamp ligand and ampf complexes 1, 2, 3 against the selected test lines is very 
different (see data in Table 3). The common feature of all compounds is that their cytotoxicity against human 
non-tumor MRC-5 cell line is negligible. The cytotoxicity of aamp for HT29 is comparable to that of the 
Doxorubicin, but without cytotoxic effect against MRC-5 cell line. Aamp shows low or no activity against K562 
and HeLa cell line, respectively. The activity of 1 is moderate against HeLa cell line but negligible against the 
two other tumor cell lines. This feature of 1 might be a consequence of the absence of the nitrato group. 
According to literature data [9] in some cell lines copper(II) is reduced to copper(I) that induces production of 
reactive oxygen species (ROS) with significant cytotoxic effect against human tumor cells. This reduction could 
be prevented by the presence of nitrato group in 2. However, the reason for the different cytotoxicity of the 
compounds against HeLa has not yet been determined. For HT29 line the complexes show moderate 
cytotoxicity, in the increasing order of 1 < 2 < 3. The activity of the complexes is very low or negligible against 
K563 tumor cells.  
Experimental for cytotoxicity in vitro 
Three human tumor cell lines and one human non-tumor cell line were used in the study: K562 (Chronic 
myelogenous leukemia), HeLa (Epitheloid carcinoma of cervix), HT29 (Colon adenocarcinoma), and MRC-5 
(Lung foetal fibroblasts). The cells were grown in RPMI 1640 (K562 cells) or Dulbecco’s modified Eagle’s 
medium (DMEM) with 4.5% of glucose (HeLa, HT29, and MRC-5 cells). Media were supplemented with 10% 
of fetal calf serum (FCS, NIVNS) and antibiotics: 100 IU/cm3 of penicillin and 100 μg/cm3 of streptomycin 
(ICN Galenika). All cell lines were cultured in flasks (Costar, 25 cm2) at 37 oC in the 100% humidity 
atmosphere and 5% of CO2. Only viable cells were used in the assay. Viability was determined by dye exclusion 
assay with Trypan blue. Cytotoxicity was evaluated by colorimetric SRB assay after Skehan et al. [10]. Briefly, 
single cell suspension was plated into 96-well microtitar plates (Costar, flat bottom): 1·104 of K562 and 5·103 of 
HeLa, HT29, and MRC5 cells, per 180 cm3 of medium. Plates were preincubated 24 h at 37 oC, 5% CO2. Tested 
substances at concentration ranging from 10–8 mol dm–3 to 10–4 mol dm–3 were added to all wells except to the 
control ones. After the incubation period (48 h /37 oC /5% CO2) SRB assay was carried out as follows: 50 μl of 
80% trichloroacetic acid (TCA), was added to all wells; an hour later plates were washed with distilled water, 
and 75 μl of 0.4% SRB was added to all wells; half an hour later plates were washed with citric acid (1%) and 
dried at room temperature. Finally, 200 μl of 10 mmol TRIS (pH=10.5) basis was added to all wells. 
Absorbance was measured on the microplate reader (Multiscan MCC340, Labsystems) at 540/690 nm. The 
wells without cells, containing compete medium only, were taken as blank. Cytotoxicity was calculated 
according to the formula (1 – Atest/Acontrol) × 100 and expressed as a percent of cytotoxicity (CI%).  
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